Authors: Sreerama, L Sladek, NE

Citation: L. Sreerama et Ne. Sladek, Primary breast tumor levels of suspected molecular determinants of cellular sensitivity to cyclophosphamide, ifosfamide, and certain other anticanceragents as predictors of paired metastatic tumor levels of these determinants - Rational individualization of cancer chemotherapeutic regimens, CANC CHEMOT, 47(3), 2001, pp. 255-262

Authors: Sladek, NE Rekha, GK Lee, MJC Nagasawa, HT

Citation: Ne. Sladek et al., Inhibition of ALDH3A1-catalyzed oxidation by chlorpropamide analogues (vol130, pg 135, 2001), CHEM-BIO IN, 138(2), 2001, pp. 199

Authors: Sladek, NE Rekha, GK Lee, MJC Nagasawa, HT

Citation: Ne. Sladek et al., Inhibition of ALDH3A1-catalyzed oxidation by chlorpropamide analogues, CHEM-BIO IN, 130(1-3), 2001, pp. 135-149

Authors: Sreerama, L Sladek, NE

Citation: L. Sreerama et Ne. Sladek, Three different stable human breast adenocarcinoma sublines that overexpress ALDH3A1 and certain other enzymes, apparently as a consequence of constitutively upregulated gene transcription mediated by transactivated EpREs (electrophile responsive elements) present in the 5 '-upstream regions of these genes, CHEM-BIO IN, 130(1-3), 2001, pp. 247-260

Authors: Sladek, NE

Citation: Ne. Sladek, Aldehyde dehydrogenase-mediated cellular relative insensitivity to the oxazaphosphorines, CUR PHARM D, 5(8), 1999, pp. 607-625